You are here: Home > Investor Relations > Acknowledge Preamble

 Investor Relations

 
 

 

NOTE:

News releases are archived on this Web site for historical purposes only. Information in the releases is accurate at the time of release. However, specific information may change over time. Information as stated in the release may or may not be in effect after the date on the release. 

 

Elite Pharmaceuticals, Inc. 165 Ludlow Ave., Northvale, NJ 07647    Phone:  201-750-2646  Fax:  201-750-2755 
E Mail:  webmaster@elitepharma.com